Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial

Leggi l'articolo originale


Journal of Clinical Oncology, Ahead of Print.

Lascia un commento